DARRELAN MCBRIDE: Open Payments
NPI 1881323459 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 13 payments from 9 companies in 2025. Trend: 2023 $794 · 2024 $3,759 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 4 | $75 |
| Abbott Laboratories | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Amgen Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Mannkind Corporation | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: iLet Bionic Pancreas, TZIELD, Kerendia, OCTRODE, REPATHA, PROCLAIM, Rybelsus, SYNTHROID.
Industry payments across AZ — which companies pay providers there.
